Iliac bone biopsies at the time of periarticular stress fractures during fluoride therapy: comparison with pretreatment biopsies.
We attempted to establish whether systemic changes in trabecular bone explain the development of stress fractures in the lower limbs during fluoride therapy for osteoporosis. To this end we compared transiliac bone biopsies obtained before treatment with those taken around the time of stress fractures after 14.3 +/- 10.9 (SD) months of therapy in six patients (group A). Biopsies from a comparable group of six patients without stress fractures at the time of the second biopsy (after 11.9 +/- 2.7 months of treatment) served for comparison (group B). The biopsies were processed undecalcified and examined by routine histomorphometry. The second biopsies did not show any significant improvement in mean bone volume or trabecular architecture. Although the second biopsies in group A had increased erosion surfaces (p less than 0.05) and greater osteoid volume (p less than 0.05), group B biopsies showed no difference in erosion surfaces but an increase in all osteoid parameters: osteoid volume (p less than 0.05), osteoid surface (p less than 0.05), and osteoid seam thickness (p less than 0.01). We reached the following conclusions: (1) the combination of increased erosion and replacement of removed bone by as yet unmineralized osteoid in the stress fracture group must have weakened bone and allowed the development of stress fractures. (2) Stress fracture patients may have mounted a less vigorous osteoblast response to fluoride than non-stress fracture patients. Under these conditions microfractures are likely to heal poorly and propagate to develop into full stress fractures. (3) Renal failure is a contraindication to fluoride therapy.
Schnitzler
C M
CM
Department of Orthopaedic Surgery, University of the Witwatersrand, Johannesburg, South Africa.
Mesquita
J M
JM
Gear
K A
KA
Robson
H J
HJ
Moodley
G P
GP
Smyth
A E
AE
D001706:Biopsy; D003404:Creatinine / Q000097:blood; D005260:Female; D015775:Fractures, Stress / Q000139:chemically induced / Q000209:etiology / Q000473:pathology*; D006620:Hip Fractures / Q000139:chemically induced / Q000209:etiology / Q000473:pathology*; D006801:Humans; D007085:Ilium / Q000187:drug effects* / Q000473:pathology; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000097:blood; D012969:Sodium Fluoride / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D013997:Time Factors
D010281:Parathyroid Hormone; D012969:Sodium Fluoride; D003404:Creatinine